Industry: Service & Software
Published Date: 2026-03-24
Pages: 95 Pages
Report ld: 6267973
Request Sample
Customized Report
Digital Pathology Image Analysis Software for Clinical Market Size(US$)

CAGR 2026-2032
8.8%
Market Size,2032
USD 675
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 675 million by 2032 with a CAGR of 8.8% during the forecast period 2026-2032.
Digital Pathology Image Analysis Software for Clinical Use refers to specialized software that assists pathologists in the analysis, interpretation, and quantification of digital images of tissue samples. These images are typically acquired through digital slide scanners, which convert glass slides into high-resolution digital images. The software is designed to support clinical decision-making by enhancing diagnostic accuracy, automating time-consuming tasks, and providing advanced tools for quantitative analysis.
In 2025, the North America Digital Pathology Image Analysis Software for Clinical market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Digital Pathology Image Analysis Software for Clinical include Indica Labs, Visiopharm, Leica Biosystems, Media Cybernetics, DSA, QuPath, Visio Pharm, 4D Path, Hologic, Gestalt Diagnostics, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Digital Pathology Image Analysis Software for Clinical market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Digital Pathology Image Analysis Software for Clinical value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Web-base Type
1.2.3 Desktop Type
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Scientific Research
1.3.3 Medical Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Pathology Image Analysis Software for Clinical Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Digital Pathology Image Analysis Software for Clinical Market Share by Revenue, by Region (2021-2026)
2.4 Global Digital Pathology Image Analysis Software for Clinical Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Digital Pathology Image Analysis Software for Clinical Market Size and Prospective (2021-2032)
2.5.2 Europe Digital Pathology Image Analysis Software for Clinical Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Size and Prospective (2021-2032)
2.5.4 Latin America Digital Pathology Image Analysis Software for Clinical Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Digital Pathology Image Analysis Software for Clinical Historical Market Size by Type (2021-2026)
3.2 Global Digital Pathology Image Analysis Software for Clinical Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Digital Pathology Image Analysis Software for Clinical
4 Breakdown Data by Application
4.1 Global Digital Pathology Image Analysis Software for Clinical Historical Market Size by Application (2021-2026)
4.2 Global Digital Pathology Image Analysis Software for Clinical Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Digital Pathology Image Analysis Software for Clinical Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Digital Pathology Image Analysis Software for Clinical Players by Revenue (2021-2026)
5.1.2 Global Digital Pathology Image Analysis Software for Clinical Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Digital Pathology Image Analysis Software for Clinical Revenue
5.4 Global Digital Pathology Image Analysis Software for Clinical Market Concentration Analysis
5.4.1 Global Digital Pathology Image Analysis Software for Clinical Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Digital Pathology Image Analysis Software for Clinical Revenue in 2025
5.5 Global Key Players of Digital Pathology Image Analysis Software for Clinical Head Offices and Areas Served
5.6 Global Key Players of Digital Pathology Image Analysis Software for Clinical, Product and Application
5.7 Global Key Players of Digital Pathology Image Analysis Software for Clinical, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Digital Pathology Image Analysis Software for Clinical Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Digital Pathology Image Analysis Software for Clinical Market Size by Type (2021-2026)
6.1.2.2 North America Digital Pathology Image Analysis Software for Clinical Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Digital Pathology Image Analysis Software for Clinical Market Size by Application (2021-2026)
6.1.3.2 North America Digital Pathology Image Analysis Software for Clinical Market Share by Application (2021-2026)
6.1.4 North America Digital Pathology Image Analysis Software for Clinical Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Digital Pathology Image Analysis Software for Clinical Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Digital Pathology Image Analysis Software for Clinical Market Size by Type (2021-2026)
6.2.2.2 Europe Digital Pathology Image Analysis Software for Clinical Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Digital Pathology Image Analysis Software for Clinical Market Size by Application (2021-2026)
6.2.3.2 Europe Digital Pathology Image Analysis Software for Clinical Market Share by Application (2021-2026)
6.2.4 Europe Digital Pathology Image Analysis Software for Clinical Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Digital Pathology Image Analysis Software for Clinical Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Digital Pathology Image Analysis Software for Clinical Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Digital Pathology Image Analysis Software for Clinical Market Size by Type (2021-2026)
6.4.2.2 Latin America Digital Pathology Image Analysis Software for Clinical Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Digital Pathology Image Analysis Software for Clinical Market Size by Application (2021-2026)
6.4.3.2 Latin America Digital Pathology Image Analysis Software for Clinical Market Share by Application (2021-2026)
6.4.4 Latin America Digital Pathology Image Analysis Software for Clinical Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Indica Labs
7.1.1 Indica Labs Company Details
7.1.2 Indica Labs Business Overview
7.1.3 Indica Labs Digital Pathology Image Analysis Software for Clinical Introduction
7.1.4 Indica Labs Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.1.5 Indica Labs Recent Development
7.2 Visiopharm
7.2.1 Visiopharm Company Details
7.2.2 Visiopharm Business Overview
7.2.3 Visiopharm Digital Pathology Image Analysis Software for Clinical Introduction
7.2.4 Visiopharm Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.2.5 Visiopharm Recent Development
7.3 Leica Biosystems
7.3.1 Leica Biosystems Company Details
7.3.2 Leica Biosystems Business Overview
7.3.3 Leica Biosystems Digital Pathology Image Analysis Software for Clinical Introduction
7.3.4 Leica Biosystems Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.3.5 Leica Biosystems Recent Development
7.4 Media Cybernetics
7.4.1 Media Cybernetics Company Details
7.4.2 Media Cybernetics Business Overview
7.4.3 Media Cybernetics Digital Pathology Image Analysis Software for Clinical Introduction
7.4.4 Media Cybernetics Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.4.5 Media Cybernetics Recent Development
7.5 DSA
7.5.1 DSA Company Details
7.5.2 DSA Business Overview
7.5.3 DSA Digital Pathology Image Analysis Software for Clinical Introduction
7.5.4 DSA Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.5.5 DSA Recent Development
7.6 QuPath
7.6.1 QuPath Company Details
7.6.2 QuPath Business Overview
7.6.3 QuPath Digital Pathology Image Analysis Software for Clinical Introduction
7.6.4 QuPath Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.6.5 QuPath Recent Development
7.7 Visio Pharm
7.7.1 Visio Pharm Company Details
7.7.2 Visio Pharm Business Overview
7.7.3 Visio Pharm Digital Pathology Image Analysis Software for Clinical Introduction
7.7.4 Visio Pharm Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.7.5 Visio Pharm Recent Development
7.8 4D Path
7.8.1 4D Path Company Details
7.8.2 4D Path Business Overview
7.8.3 4D Path Digital Pathology Image Analysis Software for Clinical Introduction
7.8.4 4D Path Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.8.5 4D Path Recent Development
7.9 Hologic
7.9.1 Hologic Company Details
7.9.2 Hologic Business Overview
7.9.3 Hologic Digital Pathology Image Analysis Software for Clinical Introduction
7.9.4 Hologic Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.9.5 Hologic Recent Development
7.10 Gestalt Diagnostics
7.10.1 Gestalt Diagnostics Company Details
7.10.2 Gestalt Diagnostics Business Overview
7.10.3 Gestalt Diagnostics Digital Pathology Image Analysis Software for Clinical Introduction
7.10.4 Gestalt Diagnostics Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.10.5 Gestalt Diagnostics Recent Development
7.11 Proscia
7.11.1 Proscia Company Details
7.11.2 Proscia Business Overview
7.11.3 Proscia Digital Pathology Image Analysis Software for Clinical Introduction
7.11.4 Proscia Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.11.5 Proscia Recent Development
7.12 Roche Diagnostics
7.12.1 Roche Diagnostics Company Details
7.12.2 Roche Diagnostics Business Overview
7.12.3 Roche Diagnostics Digital Pathology Image Analysis Software for Clinical Introduction
7.12.4 Roche Diagnostics Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.12.5 Roche Diagnostics Recent Development
7.13 Dipath
7.13.1 Dipath Company Details
7.13.2 Dipath Business Overview
7.13.3 Dipath Digital Pathology Image Analysis Software for Clinical Introduction
7.13.4 Dipath Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.13.5 Dipath Recent Development
7.14 iDeepWise
7.14.1 iDeepWise Company Details
7.14.2 iDeepWise Business Overview
7.14.3 iDeepWise Digital Pathology Image Analysis Software for Clinical Introduction
7.14.4 iDeepWise Revenue in Digital Pathology Image Analysis Software for Clinical Business (2021-2026)
7.14.5 iDeepWise Recent Development
8 Digital Pathology Image Analysis Software for Clinical Market Dynamics
8.1 Digital Pathology Image Analysis Software for Clinical Industry Trends
8.2 Digital Pathology Image Analysis Software for Clinical Market Drivers
8.3 Digital Pathology Image Analysis Software for Clinical Market Challenges
8.4 Digital Pathology Image Analysis Software for Clinical Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 378 million in 2025 to US$ 675 million by 2032, at a CAGR of 8.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 132
USD 4900.00
(Single User License)
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 675 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 102
USD 3950.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 675 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 117
USD 2900.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 93
USD 4250.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 351 million in 2024 to US$ 626 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 133
USD 4900.00
(Single User License)
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 104
USD 3950.00
(Single User License)
The global market for Digital Pathology Image Analysis Software for Clinical was valued at US$ 351 million in the year 2024 and is projected to reach a revised size of US$ 626 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-03-12
Pages: 90
USD 2900.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical revenue was US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published Date: 2024-12-12
Pages: 120
USD 4350.00
(Single User License)
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published Date: 2024-12-12
Pages: 119
USD 3950.00
(Single User License)
Valued at US$ 351 million in 2024, the global Digital Pathology Image Analysis Software for Clinical market is forecast to reach US$ 580 million by 2030, at a CAGR of 8.8% during the forecast period.
Published Date: 2024-12-12
Pages: 139
USD 4900.00
(Single User License)
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 378 million in 2025 to US$ 675 million by 2032, at a CAGR of 8.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 132
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 675 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-01-19
Pages: 102
The global Digital Pathology Image Analysis Software for Clinical market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 675 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-01-08
Pages: 117
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 93
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 351 million in 2024 to US$ 626 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 133
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 104
The global market for Digital Pathology Image Analysis Software for Clinical was valued at US$ 351 million in the year 2024 and is projected to reach a revised size of US$ 626 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-03-12
Pages: 90
The global Digital Pathology Image Analysis Software for Clinical revenue was US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published: 2024-12-12
Pages: 120
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published: 2024-12-12
Pages: 119
Valued at US$ 351 million in 2024, the global Digital Pathology Image Analysis Software for Clinical market is forecast to reach US$ 580 million by 2030, at a CAGR of 8.8% during the forecast period.
Published: 2024-12-12
Pages: 139
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now